Skip to content

Insider · CIK 0001585160

Robert E Landry

director

Files at CYTK (CYTOKINETICS INC), ZYME (Zymeworks Inc.). First filing Sep 11, 2026, latest Sep 15, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $147k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

CYTK: CYTOKINETICS INC

CYTKOct 9, 2026 · close 62.91

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
23Weak
CYTKsell 410b5-1
CYTOKINETICS INC
$72k
1,000 shares
-11%-
18Weak
CYTKsell 410b5-1
CYTOKINETICS INC
$75k
1,000 shares
-10%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 15, 2026CYTK
CYTOKINETICS INC
SOpen-market sale
Common Stock10b5-1
-1,000$72.13$72k8,18427 d ago
Sep 11, 2026CYTK
CYTOKINETICS INC
SOpen-market sale
Common Stock10b5-1
-1,000$74.66$75k9,18431 d ago
Aug 11, 2025ZYME
Zymeworks Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+62,000$0.00$062,000Aug 12, 2025
May 14, 2025CYTK
CYTOKINETICS INC
AGrant or award
Common Stock
+7,333$0.00$07,333May 14, 2025
May 14, 2025CYTK
CYTOKINETICS INC
AGrant or award
Non-Qualified Stock Option (Right to Buy)derivative
+10,880$0.00$010,880May 14, 2025
Feb 10, 2025CYTK
CYTOKINETICS INC
AGrant or award
Non-Qualified Stock Option (Right to Buy)derivative
+25,538$0.00$025,538Feb 11, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Robert E Landry: insider trades and track record | InsiderTell